Literature DB >> 28139946

Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes.

Alex Fong1, Cindy T Chau2, Cara Quant3, Jennifer Duffy2, Deyu Pan4, Dotun A Ogunyemi5.   

Abstract

OBJECTIVE: We sought to describe the prevalence, sociodemographic features, and antenatal/peripartum outcomes of multiple sclerosis (MS) in pregnancy. STUDY
DESIGN: A retrospective cohort study was performed using deliveries in California from 2001 to 2009. Cases of MS as well as other morbidities were identified via ICD-9-CM code. Logistic regression was performed to adjust for potential confounders.
RESULTS: About 1185 out of 4,424,049 deliveries were complicated by MS. MS prevalence increased with maternal age, with Caucasians comprising a higher proportion of MS subjects. MS subjects were older and more likely to have private insurance. Women with MS were more likely to have preexisting medical conditions such as asthma, chronic hypertension, thyroid disease, or cardiac disease. However, no significant antepartum and peripartum morbidities were found to be increased in patients with MS. Urinary tract infection, cesarean delivery, and induction of labor were slightly increased in MS patients.
CONCLUSIONS: MS is a rare condition which is more likely to affect older Caucasian women of higher socioeconomic status and is associated with several preexisting medical conditions. MS, however, does not appear to pose significant increases in adverse pregnancy outcome. This suggests that pregnant patients with MS may likely experience an uneventful pregnancy.

Entities:  

Keywords:  Multiple sclerosis; pregnancy; pregnancy outcomes

Mesh:

Year:  2017        PMID: 28139946     DOI: 10.1080/14767058.2017.1286314

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

Review 1.  An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis.

Authors:  Caila Vaughn; Aisha Bushra; Channa Kolb; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

2.  Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis: A Nationwide Danish Cross-sectional Study.

Authors:  Johanna Balslev Andersen; Tine Iskov Kopp; Finn Sellebjerg; Melinda Magyari
Journal:  Neurol Clin Pract       Date:  2021-02-03

3.  Pregnancy Outcomes in Women With Multiple Sclerosis.

Authors:  Sarah C MacDonald; Thomas F McElrath; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

4.  Insights into Initial Demyelinating Episodes of Central Nervous System during Puerperium.

Authors:  Qian Wu; Bo Chen; Na Liu; Yang Hu; Chao Pan; Ping Zhang; Zhou-Ping Tang; Bi-Tao Bu
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

5.  Pregnancy rates and outcomes in women with and without MS in the United States.

Authors:  Maria K Houtchens; Natalie C Edwards; Gary Schneider; Kevin Stern; Amy L Phillips
Journal:  Neurology       Date:  2018-09-28       Impact factor: 9.910

6.  Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register Study.

Authors:  Johanna Balslev Andersen; Julie Yoon Moberg; Tim Spelman; Melinda Magyari
Journal:  Front Immunol       Date:  2018-11-23       Impact factor: 7.561

7.  In Vivo Assessment of the Ameliorative Impact of Some Medicinal Plant Extracts on Lipopolysaccharide-Induced Multiple Sclerosis in Wistar Rats.

Authors:  Rabia Rasool; Inam Ullah; Samiah Shahid; Bismillah Mubeen; Syed Sarim Imam; Sultan Alshehri; Mohammed M Ghoneim; Sami I Alzarea; Bibi Nazia Murtaza; Muhammad Shahid Nadeem; Imran Kazmi
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

Review 8.  The Intersection of Disability and Pregnancy: Risks for Maternal Morbidity and Mortality.

Authors:  Caroline Signore; Maurice Davis; Candace M Tingen; Alison N Cernich
Journal:  J Womens Health (Larchmt)       Date:  2020-11-19       Impact factor: 2.681

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.